Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Akram Y. Elgendy
Does Gender Influence the Cardiovascular Benefits Observed With Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors? A Meta-Regression Analysis
Cardiology and Therapy
Related publications
Pdb1 - Acute Renal Outcomes With Sodium Glucose Co-Transporter 2 Inhibitors- Real World Data Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Sodium‐glucose Co‐transporter Type‐2 Inhibitors: Is the Message Getting Through?
Anaesthesia
Anesthesiology
Pain Medicine
Sodium–glucose Co-Transporter 2 Inhibitors: Think Twice About Diabetic Ketoacidosis
Sodium-Glucose Co-Transporter-2 Inhibitors in Type 1 Diabetes—a Dangerous Ally
US Endocrinology
Endocrinology
Metabolism
Diabetes
Sodium‐glucose Co‐transporter Type‐2 Inhibitors: Is the Message Getting Through? A Reply
Anaesthesia
Anesthesiology
Pain Medicine
Sodium-Glucose Co-Transporter Type-2 Inhibitors: Pharmacology and Peri-Operative Considerations
Anaesthesia
Anesthesiology
Pain Medicine
Sodium-Glucose Co-Transporter 2 Inhibitors: A Review of Their Use in Older People With Type 2 Diabetes Mellitus
Journal of Pharmacy Practice and Research
Pharmacology
Pharmacy
Cardiovascular Effects of Sodium Glucose Cotransporter 2 Inhibitors
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Sodium-Glucose Co-Transporter 2 Inhibitors in the Peri-Operative Period: A Warning to All Clinicians
BJU International
Urology